We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

7 hedge funds and large institutions have $87.3K invested in China Pharma Holdings in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

17% more funds holding

Funds holding: 6 → 7 (+1)

13% more capital invested

Capital invested by funds: $77K → $87.3K (+$10.3K)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
Millennium Management
New York
+$27.3K
2
UBS Group
UBS Group
Switzerland
+$9.27K
3
TSS
Two Sigma Securities
New York
+$4.7K

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$2.93K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$33K -$2.93K -48 -7%
Millennium Management
2
Millennium Management
New York
$24K +$27.3K +447 +733%
BCM
3
Bridgeway Capital Management
Texas
$13.9K – – –
UBS Group
4
UBS Group
Switzerland
$7.58K +$9.27K +152 New
TSS
5
Two Sigma Securities
New York
$5.64K +$4.7K +77 +188%
Two Sigma Advisers
6
Two Sigma Advisers
New York
$2.2K – – –
FCT
7
First Community Trust
Iowa
$1K – – –

CPHI Hedge Fund Activity: Q4 2022 in Review

7 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2022, worth a combined $87.3K — up 13% from $77K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CPHI positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Millennium Management, adding an estimated $27.3K. The largest seller was Renaissance Technologies, cutting an estimated $2.93K.

  • 7 institutional investors held China Pharma Holdings (CPHI) as of Q4 2022, up from 6 in Q3 2022.
  • Funds reported $87.3K of China Pharma Holdings stock for Q4 2022, up 13% quarter-over-quarter.
  • 1 fund opened new China Pharma Holdings positions in Q4 2022 and 0 closed out, a net change of +1 holder.
  • The largest China Pharma Holdings buyer in Q4 2022 was Millennium Management, an estimated $27.3K added.
  • The largest China Pharma Holdings seller in Q4 2022 was Renaissance Technologies, an estimated $2.93K sold.

Based on aggregated 13F filings for Q4 2022.